Literature DB >> 6725259

Importance of intramolecular interactions in the control of the fibrin affinity and activation of human plasminogen.

L Bányai, L Patthy.   

Abstract

Incubation of human Glu-plasminogen with 1,5-difluoro-2,4-dinitrobenzene leads to the specific intra-molecular cross-linking of the kringle 1+2+3 region and the light (B) chain region of plasminogen. This cross-link was found to prevent the conformational change which is induced in Glu-plasminogen by lysine analogues or by proteolytic removal of the NH2-terminal peptide. Our results suggest that the cross-link freezes the closed conformation of Glu-plasminogen, and it seems likely that the transition to the loose conformer requires separation of the kringle 1+2+3 region from the light (B) chain portion. The change in the relative position of these regions during the conformational change in plasminogen is also indicated by our observation that the rate of formation of the intramolecular cross-link is significantly decreased when transition to the loose conformer is induced either by saturation of the lysine-binding sites or by conversion to Lys-plasminogen. Cross-linked Glu-plasminogen is slowly activated by urokinase and melanoma tissue plasminogen activator, but in contrast with uncross-linked Glu-plasminogen conversion to Lys-plasminogen or saturation of lysine-binding sites with ligand does not increase the rate of activation because the cross-link prevents transition to the loose conformer which is susceptible to activation. The fibrin affinity of cross-linked Glu-plasminogen is practically identical with that of Glu-plasminogen. As in the case of uncross-linked Glu-plasminogen, removal of the NH2-terminal peptide causes a marked increase in fibrin affinity although the resulting cross-linked Lys-plasminogen is fixed in the closed conformation. This result suggests that the NH2-terminal peptide inhibits binding of plasminogen to fibrin by direct interaction with the fibrin-binding site, and the conformational change that normally accompanies its removal is not a prerequisite of strong binding.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6725259

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  5 in total

1.  The gelatin-binding site of human 72 kDa type IV collagenase (gelatinase A).

Authors:  L Bányai; H Tordai; L Patthy
Journal:  Biochem J       Date:  1994-03-01       Impact factor: 3.857

2.  Soluble fibrin degradation products potentiate tissue plasminogen activator-induced fibrinogen proteolysis.

Authors:  J I Weitz; B Leslie; J Ginsberg
Journal:  J Clin Invest       Date:  1991-03       Impact factor: 14.808

3.  BBA70 of Borrelia burgdorferi is a novel plasminogen-binding protein.

Authors:  Arno Koenigs; Claudia Hammerschmidt; Brandon L Jutras; Denys Pogoryelov; Diana Barthel; Christine Skerka; Dominik Kugelstadt; Reinhard Wallich; Brian Stevenson; Peter F Zipfel; Peter Kraiczy
Journal:  J Biol Chem       Date:  2013-07-16       Impact factor: 5.157

4.  Platelet thrombospondin forms a trimolecular complex with plasminogen and histidine-rich glycoprotein.

Authors:  R L Silverstein; L L Leung; P C Harpel; R L Nachman
Journal:  J Clin Invest       Date:  1985-06       Impact factor: 14.808

5.  The unique architecture and function of cellulose-interacting proteins in oomycetes revealed by genomic and structural analyses.

Authors:  Mathieu Larroque; Roland Barriot; Arnaud Bottin; Annick Barre; Pierre Rougé; Bernard Dumas; Elodie Gaulin
Journal:  BMC Genomics       Date:  2012-11-09       Impact factor: 3.969

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.